-
-
-
-
-
-
-
Qiagen guides to at least 5% sales growth in 2026
-
-
-
-
-
-
-
Qiagen NV (QGEN) PT Lowered to $48 at CFRA
-
-
-
-
-
-
-
QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds
-
-
-
-
-
-
-
QIAGEN Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics With NGS Technologies
-
-
-
-
-
-
-
QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds and Price to Non-US Holders to Sell Outstanding Convertible Notes Due 2021
-
-
-
-
-
-
-
QIAGEN (QGEN) to Continue Growth Strategy Focused on Execution and Greater Value Creation
-
-
-
-
-
-
-
QIAGEN announces publication of Supplemental Reasoned Position Statement for proposed acquisition by Thermo Fisher
-
1,182,407 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

